D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
Starbucks
SBUX
|
+$370M |
| 3 |
Pfizer
PFE
|
+$338M |
| 4 |
PayPal
PYPL
|
+$320M |
| 5 |
Charles Schwab
SCHW
|
+$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$415M |
| 4 |
Citigroup
C
|
+$312M |
| 5 |
Booking.com
BKNG
|
+$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMDX
3201
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$88.1M
| $366K | ﹤0.01% |
12,293
-4,062
| -25% | -$121K |
|
|
AVLR
3202
DELISTED
Avalara, Inc.
AVLR
| $366K | ﹤0.01% |
3,677
+491
| +15% | +$48.9K |
|
3203
Korea Electric Power
KEP
$17.2B
| $364K | ﹤0.01% |
39,091
+19,563
| +100% | +$182K |
|
|
RUMBW
3204
Rumble Inc. Warrant
RUMBW
$755M
| $364K | ﹤0.01% |
107,072
-3,579
| -3% | -$12.2K |
|
|
OPNT
3205
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $364K | ﹤0.01% |
+16,989
| New | +$364K |
|
3206
Tredegar Corp
TG
$279M
| $363K | ﹤0.01% |
30,281
+19,775
| +188% | +$237K |
|
|
PNNT
3207
Pennant Park Investment Corp
PNNT
$464M
| $362K | ﹤0.01% |
+46,546
| New | +$362K |
|
3208
Powell Industries
POWL
$3.47B
| $362K | ﹤0.01% |
18,642
+4,301
| +30% | +$83.5K |
|
3209
Nature's Sunshine
NATR
$299M
| $360K | ﹤0.01% |
21,379
-28,404
| -57% | -$478K |
|
3210
NiSource
NI
$19.3B
| $360K | ﹤0.01% |
11,322
-620,832
| -98% | -$19.7M |
|
|
SLVRW
3211
DELISTED
SilverSPAC Inc. Warrant
SLVRW
| $360K | ﹤0.01% |
825,000
| – | – |
|
3212
International Flavors & Fragrances
IFF
$16.8B
| $359K | ﹤0.01% |
+2,734
| New | +$359K |
|
3213
Instil Bio
TIL
$163M
| $359K | ﹤0.01% |
1,672
+1,141
| +215% | +$245K |
|
3214
Janus Henderson
JHG
$7.01B
| $358K | ﹤0.01% |
10,224
-10,600
| -51% | -$371K |
|
3215
CVRx
CVRX
$205M
| $357K | ﹤0.01% |
+59,578
| New | +$357K |
|
|
NWLI
3216
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $357K | ﹤0.01% |
1,698
+81
| +5% | +$17K |
|
3217
MarketWise
MKTW
$49.2M
| $356K | ﹤0.01% |
+3,769
| New | +$356K |
|
3218
NeoGenomics
NEO
$1.03B
| $356K | ﹤0.01% |
+29,299
| New | +$356K |
|
3219
Grand Canyon Education
LOPE
$5.89B
| $352K | ﹤0.01% |
3,622
-30,380
| -89% | -$2.95M |
|
|
BERY
3220
DELISTED
Berry Global Group, Inc.
BERY
| $352K | ﹤0.01% |
+6,619
| New | +$352K |
|
3221
Progressive
PGR
$146B
| $351K | ﹤0.01% |
3,080
-30,832
| -91% | -$3.51M |
|
3222
Old Second Bancorp
OSBC
$961M
| $349K | ﹤0.01% |
24,065
+9,907
| +70% | +$144K |
|
|
PNT
3223
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $349K | ﹤0.01% |
43,744
-39,308
| -47% | -$314K |
|
|
JBTM
3224
JBT Marel Corporation
JBTM
$7.14B
| $347K | ﹤0.01% |
2,933
-1,328
| -31% | -$157K |
|
|
VRTV
3225
DELISTED
VERITIV CORPORATION
VRTV
| $347K | ﹤0.01% |
+2,599
| New | +$347K |
|